SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AMLN (DIABETES DRUGS) -- Ignore unavailable to you. Want to Upgrade?


To: richardred who wrote (1812)4/26/2005 9:13:22 AM
From: arnie h  Read Replies (1) | Respond to of 2173
 
Interesting insider sale yesterday. Alain Baron, SR. VP Research exercised an option for 933 shares at $7 and sold immediately at $19. Yesterday was the 1st day the option could be exercised but didn't expire until '09. Still owns 6500 shares so this may be some kind of an auto strategy but I wonder about selling so close to when the FDA is supposed to decide on Exenatide. Hard to believe he needed a quick $17K.